Correlation Between Sana Biotechnology and 10X Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and 10X Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and 10X Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and 10X Genomics, you can compare the effects of market volatilities on Sana Biotechnology and 10X Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of 10X Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and 10X Genomics.

Diversification Opportunities for Sana Biotechnology and 10X Genomics

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Sana and 10X is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and 10X Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 10X Genomics and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with 10X Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 10X Genomics has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and 10X Genomics go up and down completely randomly.

Pair Corralation between Sana Biotechnology and 10X Genomics

Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the 10X Genomics. In addition to that, Sana Biotechnology is 1.5 times more volatile than 10X Genomics. It trades about -0.2 of its total potential returns per unit of risk. 10X Genomics is currently generating about -0.02 per unit of volatility. If you would invest  1,633  in 10X Genomics on September 2, 2024 and sell it today you would lose (43.00) from holding 10X Genomics or give up 2.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Sana Biotechnology  vs.  10X Genomics

 Performance 
       Timeline  
Sana Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sana Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
10X Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 10X Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Sana Biotechnology and 10X Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sana Biotechnology and 10X Genomics

The main advantage of trading using opposite Sana Biotechnology and 10X Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, 10X Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 10X Genomics will offset losses from the drop in 10X Genomics' long position.
The idea behind Sana Biotechnology and 10X Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings